| Ticker: | RDOC | 829 West Stadium Lane | |
| Exchange: | NASDAQ-Small Cap Market | Sacramento, California 95834 | |
| Industry: | Manufacturing | (916) 646-3487 |
| Type of Shares: | Common Shares | Filing Date: | 7/30/96 | |
| U.S. Shares: | 1,525,000 | Offer Date: | 11/21/96 | |
| Non-U.S. Shares: | 0 | Filing Price: | $6.00 | |
| Primary Shares: | 1,525,000 | Offer Price: | $5.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.47 | |
| Offering Amount: | $9,150,000 | Selling: | $0.19 | |
| Expenses: | $586,119 | Reallowance: | $0.10 | |
| Shares Out After: | 3,351,641 |
| Manager | Tier | Phone |
| Rickel & Associates, Inc. | Lead Manager | (800) 678-2664 |
| Aegis Capital Corp. | Co-manager |
| Auditor: Ernst & Young | |||||
| 9 Month Ending Financials | |||||
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 9/30/96 | 9/30/95 | 9/30/96 | ||
| Revenue: | $0.18 | $1.75 | $0.11 | Assets: | $2.62 |
| Net Income: | -$4.99 | -$2.12 | -$3.68 | Liabilities: | $1.17 |
| EPS: | -$1.19 | -$0.48 | -$0.88 | Equity: | $1.45 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| Integrated Surgical Systems, Inc. develops, manufactures, markets and services image-directed, computer-controlled robotic products for surgical applications. The company's principal product is the ROBODOC (R) Surgical Assistant System, consisting of a computer-controlled surgical robot and the company's ORTHODOC (R) Presurgical Planner. The ROBODOC System has been used for primary total hip replacement surgery on over 425 patients worldwide. The company believes its active robotic system is the only available system that can accurately perform key segments of surgical procedures with precise tolerances generally not attainable by traditional manual surgical techniques. The ROBODOC System also allows the surgeon to prepare a preoperative plan specifically designed to the characteristics of the individual patient's anatomy. The technology for the ROBODOC System was initially developed at the University of California, Davis, in collaboration with International Business Machines Corporation. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for product development; for sales and marketing and for working capital and general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.